Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 2, 2019 1:03 PM 2 min read

Dispensary Operator iAnthus Reports $14.8M In Q4 Pro Forma Revenue

by Alex Oleinic Benzinga Staff Writer
Follow
FlipboardIcon version of the Flipboard logo

Vancouver-based cannabis company iAnthus Capital Holdings Inc (OTC:ITHUF) reported fourth-quarter financial results Tuesday, including pro forma revenue of $14.8 million.

The Cannabis Capital Conference is coming back to Toronto! Click here to learn how you can join Tim Seymour, Jon Najarian, Alan Brochstein and many others.

What Happened

The pro forma revenue figure includes MPX Bioceutical Corporation entities that iAnthus agreed to acquire in October — the deal closed in February — as well as managed revenue for Colorado and New Mexico operations.

The company's revenue and other income for the fourth quarter totaled $2.2 million, up by 165 percent on the year. 

iAnthus also posted adjusted EBITDA loss of $6 million for the quarter. 

The company closed the quarter with $168.4 million in assets, an increase from $45.8 million a year earlier on the back of acquisitions in Florida and New York and the build-out of cultivation facilities and dispensaries across operating entities. 

Why It's Important

iAnthus is one of the largest vertically integrated cannabis operators in the U.S.

The company generates revenue in nine out of 11 states where it has a presence and said it expects to start sales in California in the next 60 days. It operates 21 dispensaries across the U.S. and plans to continue to open locations in Florida, Massachusetts, New York, Nevada and New Jersey throughout the rest of 2019.

The company also has cultivation and processing facilities in nine states and distributes branded products to over 90 dispensaries. 

What's Next

iAnthus plans to continue with its expansion and, in addition to opening new dispensaries, it also has plans to extend its cultivation and processing capabilities.

The company recently announced the acquisition of national CBD brand CBD For Life and expects to close the transaction in the second quarter of 2019. 

Related Links:

Cresco Labs To Acquire Origin House In $825M Deal

For Cannabis Industry Investment, 2018 Was Terrific But 2019 Looks Even Better

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
CannabisEarningsNewsMarkets
ITHUF Logo
ITHUFiAnthus Capital Holdings Inc
$0.00410-%
Overview
ITHUF Logo
ITHUFiAnthus Capital Holdings Inc
$0.00410-%
Overview
Comments
Loading...